申请人:Threshold Pharmaceuticals, Inc.
公开号:US20140170240A1
公开(公告)日:2014-06-19
Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.
磷酰胺酸烷基化剂前药可单独或与一个或多个抗肿瘤药物联合使用治疗癌症。